Skip to content

A randomized, single-blind, controlled clinical study of remazolam toluenesulfonate in painless cystoscopy in adult male patients

A randomized, single-blind, controlled clinical study of remazolam toluenesulfonate in painless cystoscopy in adult male patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063558
Enrollment
Unknown
Registered
2022-09-11
Start date
2022-09-11
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless cystoscopy in adult male patients

Interventions

Rimazole toluenesulfonate:Remidazolam toluenesulfonate by intravenous injection

Sponsors

Leshan Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: This study needs to be approved by the hospital ethics committee. After obtaining the informed consent of patients and their families, 64 male patients, aged 18-70 years old, who are going to undergo ureteral stent removal under intravenous anesthesia in our hospital, are selected, and the American Society of anesthesiologists (ASA) grades I-III.

Exclusion criteria

Exclusion criteria: ? Preoperative blood pressure of patients >160/100 mmHg or 100bpm; ? There was acute inflammation of respiratory tract within 2 weeks and no cure history; ? Patients with serious heart, brain, lung, liver, kidney and other diseases have previous myocardial infarction, severe myocardial ischemia, and severe atrioventricular block; ? Predict the possible occurrence or past occurrence of difficult airway or abnormal surgical anesthesia recovery history; ? Known allergy to emulsion and opioid drugs; ? Those who used other sedative and analgesic drugs before operation; ? Suspected of abusing narcotic analgesics or sedatives; ? People with neuromuscular diseases, mental diseases and other uncooperative and unable to communicate; ? Previous history of erectile dysfunction; Sexual dysfunction.

Design outcomes

Primary

MeasureTime frame
heart rate;NIBP;RR;SPO2;

Secondary

MeasureTime frame
Anesthesia recovery time;Injection pain;Patient's intraoperative body movement;Patient's penis erection;

Countries

China

Contacts

Public Contactyandan

Leshan Traditional Chinese Medicine Hospital

363343825@qq.com18384682853

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026